Repare Therapeutics’ (RPTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research report sent to investors on Monday, Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Repare Therapeutics’ Q4 2023 earnings at $0.02 EPS, FY2023 earnings at ($1.55) […]
More Stories
K92 Mining (TSE:KNT) Sets New 52-Week High – Should You Buy?
K92 Mining Inc. (TSE:KNT – Get Free Report) reached a new 52-week high during trading on Wednesday . The stock...
SemiLEDs (NASDAQ:LEDS) Posts Earnings Results
SemiLEDs (NASDAQ:LEDS – Get Free Report) issued its quarterly earnings results on Friday. The semiconductor company reported ($0.08) earnings per...
Hemostemix (CVE:HEM) Stock Price Up 37.9% – Still a Buy?
Hemostemix Inc. (CVE:HEM – Get Free Report) shares traded up 37.9% on Friday . The company traded as high as...
First Majestic Silver (NYSE:AG) Receives Buy Rating from HC Wainwright
First Majestic Silver (NYSE:AG – Get Free Report) (TSE:FR)‘s stock had its “buy” rating restated by research analysts at HC...
Azincourt Energy (CVE:AAZ) Stock Price Up 50% – Time to Buy?
Shares of Azincourt Energy Corp. (CVE:AAZ – Get Free Report) rose 50% during mid-day trading on Wednesday . The company...
Oceanic Iron Ore (CVE:FEO) Shares Up 66.7% – What’s Next?
Oceanic Iron Ore Corp. (CVE:FEO – Get Free Report)’s stock price traded up 66.7% on Friday . The stock traded...